Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
The frustration experienced by these patients often stems from unrealistic expectations and inadequate medical supervision
So far, there has only been only one small randomized controlled study, looking at whether another GLP-1 drug could treat alcohol use disorder in people in general, as compared to cognitive behavioral therapy
SURMOUNT-1 reported 7.1% discontinuation with 15mg tirzepatide, while CONQUER showed 9.3% discontinuation with high-dose Qsymia
Serious but rare side effects include pancreatitis (severe abdominal pain that radiates to the back), gallbladder issues, and acute kidney injury
US$ 23.50
US$ 28.68
US$ 22.09
US$ 26.03
US$ 29.09
US$ 23.92
